✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Aurobindo Pharma Ltd.

AUROPHARMA

Market Cap
₹73,042 Cr.
P/E
20.92

Aurobindo Pharma Ltd.

About
Aurobindo Pharma Limited is a leading Active Pharmaceutical Ingredients (API) manufacturing company with a focus on cost leadership and flexibility. Its API business drives profitability and growth in… Read more
Aurobindo Pharma Limited is a leading Active Pharmaceutical Ingredients (API) manufacturing co… Read more
Low
1010
52W Range
High
1592
  • Aurobindo Pharma
  • Abbott India
  • Alkem Laboratories
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
6.80 %
(as of Mar 21)
Source/Historic
Rx Market Share - USA
Revenue mix

Product Wise Break-Up

Product Wise Break-Up - API

Location Wise Break-Up

Dosage Form Break-Up - USA Formulation

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Europe DMF Filings (.)
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Laurus Labs Ltd.
    • Navin Fluorine International Ltd.
    • Atul Ltd.
    • Neuland Laboratories Ltd.
    • Kirloskar Pneumatic Company Ltd.
    FAQs on Aurobindo Pharma Ltd. Business

    Aurobindo Pharma is a leading API manufacturing company with a strong presence in various therapeutic domains. Its advanced R&D infrastructure supports the development and delivery of new products, ensuring profitability and growth.

    Aurobindo Pharma major competitors are Abbott India, Alkem Laboratories, Zydus Lifesciences, Glaxosmithkline Phar, Lupin, Dr. Reddy's Lab, Glenmark Pharma.
    Market Cap of Aurobindo Pharma is ₹72,472 Crs.
    While the median market cap of its peers are ₹64,679 Crs.

    Aurobindo Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Aurobindo Pharma is 5.31 and is ranked 8 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Dec Mar Sep Dec Mar Jun Sep Dec Jun Sep Dec Mar Jun Sep Dec Jun Sep Sep Dec
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Dec Dec Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Aurobindo Pharma Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material